SMARCA2 and ovarian cancer: This report is the first to characterize the SE landscape of SCCOHT, an ovarian cancer subtype driven by widespread epigenetic dysregulation due to the loss of the SWI/SNF chromatin remodeling complex ATPase subunits SMARCA4 and SMARCA2.